NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK CITY, NY / ACCESS Newswire / June 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. ("PetMed" or the "Company") (NASDAQ:PETS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
DELRAY BEACH, Fla., June 16, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced preliminary fourth quarter and fiscal year 2025 results and filed Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission. The Company is unable to file its Annual Report on Form 10-K for the fiscal year ended March 31, 2025 within the prescribed time period without unreasonable effort or expense. The Company expects to file its Annual Report on Form 10-K with the Securities and Exchange Commission as soon as practicable, and no later than July 1, 2025, in accordance with Rule 12b-25.
![]() PQM 11 Aug 2023 | Other | €0.3 Per Share |
![]() PQM 5 Jun 2023 | Other | €0.3 Per Share |
![]() PQM 16 Feb 2023 | Other | €0.3 Per Share |
![]() PQM 17 Nov 2022 | Other | €0.3 Per Share |
![]() PQM 11 Aug 2022 | Other | €0.3 Per Share |
10 Jun 2025 Date | | - Cons. EPS | - EPS |
9 Jun 2025 Date | | - Cons. EPS | - EPS |
6 Feb 2025 Date | | - Cons. EPS | - EPS |
6 Nov 2024 Date | | - Cons. EPS | - EPS |
28 Oct 2024 Date | | - Cons. EPS | - EPS |
![]() PQM 11 Aug 2023 | Other | €0.3 Per Share |
![]() PQM 5 Jun 2023 | Other | €0.3 Per Share |
![]() PQM 16 Feb 2023 | Other | €0.3 Per Share |
![]() PQM 17 Nov 2022 | Other | €0.3 Per Share |
![]() PQM 11 Aug 2022 | Other | €0.3 Per Share |
10 Jun 2025 Date | | - Cons. EPS | - EPS |
9 Jun 2025 Date | | - Cons. EPS | - EPS |
6 Feb 2025 Date | | - Cons. EPS | - EPS |
6 Nov 2024 Date | | - Cons. EPS | - EPS |
28 Oct 2024 Date | | - Cons. EPS | - EPS |
Medical - Pharmaceuticals Industry | Healthcare Sector | Ms. Sandra Y. Campos CEO | XSTU Exchange | IT0004240443 ISIN |
US Country | 287 Employees | 11 Aug 2023 Last Dividend | 4 Mar 1999 Last Split | 26 Apr 1999 IPO Date |
PetMed Express, Inc., with its subsidiaries, stands as a prominent pet pharmacy within the United States, offering a comprehensive range of health care products and medications for pets since its inception in 1996. Based in Delray Beach, Florida, the company has carved out a niche in the pet care market by distributing an assortment of prescription and non-prescription medications, health products, and supplies tailored for a variety of animals including dogs, cats, and horses. PetMed Express has established a robust distribution model utilizing its website, a mobile app, customer support centers, direct mail/print advertising, and television commercials, operating under well-known brands such as 1-800-PetMeds, PetCare Rx, and PetMeds.
This category encompasses a broad selection of products aimed at enhancing pet health and well-being without the need for a veterinary prescription. Offerings include flea and tick control products to maintain pets free from pests; bone and joint care products designed to support mobility; vitamins and nutritional supplements to promote overall health; treats for rewards and training; hygiene products for grooming needs; and an assortment of supplies to ensure pets remain healthy and content.
PetMed Express provides a myriad of prescription medications catering to a wide range of health issues faced by pets. These include heartworm preventatives to protect against the heartworm disease; flea and tick preventatives to fend off these common pests; medications for managing arthritis, dermatitis, and thyroid issues; treatments for diabetes and pain; as well as heart/blood pressure medications. The company also offers generic substitutes, providing cost-effective alternatives for pet owners.
Beyond medications, the company stocks essential pet supplies such as food tailored to specific dietary needs, beds for comfort, crates for safety and transport, stairs to assist pets with mobility challenges, among other valuable accessories. These products underscore PetMed Express's commitment to catering to the comprehensive needs of pets and their owners.